TennesseeHB 1198114th General Assembly (2025-2026)HouseWALLET

AN ACT to amend Tennessee Code Annotated, Title 4; Title 53; Title 56; Title 68 and Title 71, relative to biosimilar medicine.

Sponsored By: Sponsor information unavailable

Signed by Governor

Drugs, Prescription

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

Analyzed Economic Effects

2 provisions identified: 2 benefits, 0 costs, 0 mixed.

Fewer hurdles for patients seeking brand-name drugs

The law bars insurers, health plans, and coverage reviewers from requiring patients to try certain alternatives before covering an equivalent brand-name drug. Those alternatives are an AB-rated generic equivalent, an interchangeable biological medicine, or a biosimilar. This removes a try-first requirement, but does not guarantee coverage outside that situation. The rule takes effect upon enactment.

Biosimilars added to Tennessee drug rules

Effective upon enactment, Tennessee adds biosimilars to state drug provisions, including a TennCare drug rule. The insurance and TennCare definitions require federal licensing under the biosimilar pathway and no discontinued listing in the FDA’s Purple Book. Required drug information includes biosimilars alongside generics and medicines with the same treatment effect. It includes how well drugs work and cost information for each drug. These changes do not themselves create a new coverage or payment right.

Sponsors & Cosponsors

Sponsors

There is no primary sponsor on record.

Cosponsors

  • Bryan Terry

    Republican • House

Roll Call Votes

All Roll Calls

Yes: 143 • No: 1

House vote • 3/31/2025

FLOOR VOTE: REGULAR CALENDAR AS AMENDED PASSAGE ON THIRD CONSIDERATION 3/31/2025

Yes: 92 • No: 1

House vote • 3/31/2025

HOUSE CALENDAR & RULES COMMITTEE

Yes: 0 • No: 0

Senate vote • 3/31/2025

FLOOR VOTE: Third Consideration 3/31/2025

Yes: 30 • No: 0

House vote • 3/19/2025

HOUSE INSURANCE COMMITTEE

Yes: 15 • No: 0

House vote • 3/12/2025

INSURANCE SUBCOMMITTEE

Yes: 6 • No: 0

Actions Timeline

  1. Effective date(s) 04/11/2025

    4/28/2025
  2. Pub. Ch. 206

    4/28/2025
  3. Signed by Governor.

    4/11/2025
  4. Transmitted to Governor for his action.

    4/3/2025House
  5. Signed by Senate Speaker

    4/3/2025Senate
  6. Signed by H. Speaker

    4/2/2025House
  7. Enrolled; ready for sig. of H. Speaker.

    4/2/2025House
  8. Passed Senate, Ayes 30, Nays 0

    3/31/2025Senate
  9. Amendment withdrawn. (Amendment 1 - SA0236)

    3/31/2025Senate
  10. Senate substituted House Bill for companion Senate Bill.

    3/31/2025Senate
  11. Received from House, Passed on First Consideration

    3/31/2025Senate
  12. Engrossed; ready for transmission to Sen.

    3/31/2025House
  13. Passed H., as am., Ayes 92, Nays 1, PNV 0

    3/31/2025House
  14. Sponsor(s) Added.

    3/31/2025House
  15. H. adopted am. (Amendment 1 - HA0140)

    3/31/2025House
  16. H. Placed on Regular Calendar for 3/31/2025

    3/27/2025House
  17. Placed on cal. Calendar & Rules Committee for 3/27/2025

    3/26/2025House
  18. Rec. for pass. if am., ref. to Calendar & Rules Committee

    3/19/2025House
  19. Placed on cal. Insurance Committee for 3/19/2025

    3/12/2025House
  20. Rec for pass if am by s/c ref. to Insurance Committee

    3/12/2025House
  21. Placed on s/c cal Insurance Subcommittee for 3/12/2025

    3/5/2025House
  22. Assigned to s/c Insurance Subcommittee

    2/12/2025House
  23. P2C, ref. to Insurance Committee

    2/12/2025House
  24. Intro., P1C.

    2/10/2025House
  25. Filed for introduction

    2/6/2025House

Bill Text

  • HA0140

    3/31/2025

  • Enrolled / Public Chapter

  • Fiscal Note

  • Introduced

  • SA0236

Related Bills

Back to State Legislation